Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Redcliffe Labs

Request full access

Dedicated Genetics and Genomics research company based out of Sec-63 Noida

Noida, IndiaFounded 2017Biotech & Life Sciences

About Redcliffe Labs

Redcliffe Labs operates as an omnichannel diagnostics service provider in India, founded in 2018 by Dheeraj Jain, Ashish Dubey, and Aditya Kandoi. The company was established to address the gap in accessible and affordable high-quality diagnostic services, particularly in India's smaller cities and underserved regions. Dheeraj Jain, a serial entrepreneur and angel investor with extensive experience in corporate strategy, co-founded several other ventures, including PeeSafe and Crysta IVF. The founders' collective experience in healthcare, technology, and early-stage investments shaped the company's direction. Aditya Kandoi currently serves as the CEO, with Dheeraj Jain as the Chairman of the Board.

The company's business model combines a digital-first approach with a physical network of laboratories and collection centers. Revenue is primarily generated from a comprehensive portfolio of over 3,600 diagnostic tests, ranging from routine pathology to advanced genetic screening for reproductive health, cancer, and wellness. In the fiscal year 2025, the company reported revenue of ₹419 crore, with diagnostic services accounting for over 95% of this total. Redcliffe Labs serves individuals, healthcare providers, and corporate clients, with a strategic focus on expanding its reach in Tier II and III cities, which now account for over 70% of its diagnostic volumes.

Redcliffe Labs offers a platform that enables users to book diagnostic tests online, with the convenience of at-home sample collection and same-day reporting. The service is underpinned by a network of more than 80 laboratories and over 2,000 collection centers across more than 220 cities in India. A key operational feature is the use of technology to enhance efficiency, including being a pioneer in using drones for medical sample transport. The company provides easy-to-interpret smart reports to help with timely diagnosis and treatment. To make its services widely available, Redcliffe utilizes a franchise model for its collection centers and offers various health packages and promotional discounts.

The company has achieved significant financial milestones, securing a total of $116 million in funding across several rounds. A notable Series C round in September 2024 raised $42 million, led by Denmark's Investment Fund for Developing Countries (IFU), to fuel further expansion into smaller cities. Strategic acquisitions, such as the purchase of Celara Diagnostics, are also part of its growth strategy. While the company has seen substantial revenue growth, it also reported increased losses in FY23 before significantly narrowing them in FY24 and FY25, reducing EBITDA losses from -38% to -21% in the last fiscal year.

Source: Dealroom company data

At a glance

Status
Operational
Employees
146
Open positions
None listed
Dealroom signal
56.7/100
Industry
Health
Sub-industry
BioTechnology
Sector
Biotechnology, Genetics and genomics, Genome Engineering, Biotech and Pharma, Hard Tech
Business model
Manufacturing
Client focus
B2B
Investment activity
1 company, latest Sep 2024
Capital deployed
—
Preferred round
ACQUISITION
Links
Website

Funding history

5 recorded events

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
SERIES COther financing Sep 2024 $42M $305M HealthQuad · Investment Fund for Developing Countries · LeapFrog Investments · Spark Growth Ventures ↗
SERIES BOther financing May 2022 $61M $244M Schroders · HealthQuad · LeapFrog Investments · Chiratae Ventures ↗
Showing the latest 2 of 5 recorded eventsBook a demo for the full funding history →

Growth signals

Redcliffe Labs website traffic

Latest recorded traffic for Redcliffe Labs is 740 monthly website visits, up 13.8% over the last three months. Redcliffe Labs's team grew 0% over the past year.

Latest monthly visits740 3-month web change+13.8% 1-year team growth0%
Summary metrics are public; monthly history is available with a demoCompare with peers →

Investments and acquisitions

Capital deployed

Recent portfolio relationships for companies that also act as investors or acquirers.

Redcliffe Labs in the Noida ecosystem

Live from Dealroom

The Redcliffe Labs office with the hot startups, most funded companies and investors around it. Hover or tap a pin.

Loading the map…

Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →

Investors

9 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Seed1 investor entered at this stage

  • Asymmetry Ventures

Series A7 investors entered at this stage

  • Spark Growth Ventures
  • LeapFrog Investments
  • Schroders
  • HealthQuad
  • Chiratae Ventures
  • Alkemi Growth Capital
  • LC Nueva AIF

Series B and later1 investor entered at this stage

  • Investment Fund for Developing Countries
Team profiled 1 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 1 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
🇮🇳 India · Noida HQ
Book a demo for the full country breakdown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Redcliffe Labs on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Redcliffe Labs’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.